Internationally recognised as a principal investigator and UK chief investigator for major trials: PERSEPHONE, tAnGo, plasmaMATCH, EPHOS-B, HER-2-RADiCAL, CHAT.
Founding Co-Director of the Manchester Breast Centre (2005), building one of Europe’s foremost translational research hubs.
Co-founder of the AstraZeneca–University of Manchester–Christie Alliance, precursor to the Manchester Cancer Research Centre.
Chair, NCRI Breast Research Group (2020–2022) and Chair, WG2 Metastatic Breast Cancer (2022–present).
Over 300 peer-reviewed publications, with an h-index of 57, including practice-changing trials published in The Lancet and New England Journal of Medicine.
